Ac Immune Sa  (ACIU)
Other Ticker:  


Ac Immune Sa

ACIU's Financial Statements and Analysis

Ac Immune Sa narrowed IV. Quarter net loss per share of $-0.85 compare to net loss per share of $-0.97 recorded in the same quarter a year ago a decrease compare to $0.00 realized in previous quarter.

IV. Quarter
Earnings Per Share Revenues
$ -0.85 $  0 Mill
$+0.12     Unch.    

Ac Immune Sa's Revenue fell by 0 % in IV. Quarter (Dec 31 2022) year on year, to $0 million and declined by sequentially.

Ac Immune Sa is Expected to report next financial results on March 15, 2024.

More on ACIU's Income Statement

Ac Immune Sa's in IV. Quarter recorded net loss of $-70.753 million, an improvement compare to net loss of $-72.996 million in IV. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $0.000 million in previous quarter.

More on ACIU's Growth

Ac Immune Sa Inventories
ACIU's Cash flow In IV. Quarter company's net cash flow was $82 million, capital expenditures grew by -52.98%, to $-1 millions compare to same quarter a year ago and fell by